Document is current

Article History

Received: 31 January 2025

Accepted: 22 October 2025

First Online: 25 November 2025

Declarations

:

: The project (HUM00205639) was reviewed by the University of Michigan Health and Behavioral Sciences Institutional Review Board prior to data collection. Informed consent was obtained from all participants included in the study. Participants were not compensated and could withdraw at any time.

: All authors have contributed substantially to the project and have approved the final version of this manuscript to be published.

: The authors have no competing interests to declare that are relevant to the content of this article. KFB’s effort on this publication was partially supported by the National Institute on Drug Abuse of the National Institutes of Health under K01DA049219. KFB has received grant funding from Tryp Therapeutics for protocol development. JB is the Founder/President of the Michigan Psychedelic Society and is a Psychedelic Integration and Music Therapist at Blue Sage Health Consulting. JSA’s effort on this publication was partially supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under T32AR007080-44S1.